3 Things Indian PhD scholar's visa revoked, CAR T- cell therapy, and Israel attacks Gaza
Mar 19, 2025
Anona Dutt, a reporter for The Indian Express, dives into the controversial visa revocation of Ranjini Srinivasan, an Indian PhD scholar, amidst escalating tensions surrounding campus protests. Dutt elaborates on the implications for academic freedom and the fear many scholars face. The discussion shifts to groundbreaking results from India's CAR T-cell therapy clinical trials, highlighting its promise in cancer treatment. Lastly, the podcast touches on the escalating violence in Gaza, providing a poignant backdrop to the ongoing crisis.
AI Snips
Chapters
Transcript
Episode notes
Scholar's Visa Revoked
- Ranjini Srinivasan, a Columbia University PhD scholar, self-deported after her F-1 visa was revoked.
- The revocation was allegedly due to her involvement in pro-Palestinian demonstrations and supposed support for Hamas.
Crackdown on Protesters
- The Trump administration is increasing its crackdown on foreign nationals involved in pro-Palestinian protests.
- This action is seen as aligning with Trump's broader anti-immigrant stance and campaign promises.
CAR T-Cell Therapy Breakthrough
- India's first CAR T-cell therapy trial results were published in The Lancet, showing a 73% response rate in blood cancer patients.
- This therapy offers a more affordable treatment option compared to global counterparts, costing 1/20th the price.